MedTrace Logo

The Effect of ObeseGO! Towards Adolescent Obesity

NCT02360553 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2015-03-30

No results posted yet for this study

Summary

Adolescents nowadays is having most of their times other than school hours spending on screen by playing games, watching the movies and surfing the internet. Thus, it was suggested that Internet-based interventions have the potential for establishing healthy dietary style and physical activity that may persist in adulthood and reduce the risk of chronic disease. Preventing adolescent obesity requires an attitude of willingness by adolescents to implement healthy behaviors. By providing the health related activities in website, it would help the adolescents to spend time on screen by having something which can benefit them and improve their knowledge and attitudes.

Conditions

  • Adolescent Behavioral Change

Interventions

BEHAVIORAL

ObeseGO!

The intervention group were received the obeseGO! intervention which is an internet-based intervention. The participants and the parents who are randomly chosen to enroll in this intervention group were provided with the ObeseGO! website. The website was accessed at www.obesego.com. The website consists of various informations on healthy lifestyle, diet and ways to overcome obesity.

BEHAVIORAL

Pamphlets material

The control group will be given pamphlets material on diet and physical activity.

Sponsors & Collaborators

  • Universiti Kebangsaan Malaysia Medical Centre

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2013-10-31
Completion
2013-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02360553 on ClinicalTrials.gov